Appointment booking for Dr. Francis Lichon, MD is currently not available.Dr. Francis Lichon, MD has not yet fully activated their profile on DiabetesIQ.
Dr. Francis Lichon, MD (he/him) is a Rheumatologist in Carol Stream, IL with over 17 years of experience. What is your opinion of Dr. Francis Lichon, MD? Rate this provider below so other people can make informed decision.
Gender
Male
Experience
Over 17 Years of Experience
Languages Spoken
English
Accepted Insurances
Medicare
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Francis Lichon, MD has received over $7,893 which includes payments from the following companies:
$1,997.73 from Pfizer Inc.
$1,365.19 from AbbVie, Inc.
$936.80 from Amgen Inc.
$406.72 from UCB, Inc.
$400.88 from Janssen Biotech, Inc.
$391.77 from Horizon Pharma plc
$314.17 from Novartis Pharmaceuticals Corporation
$250.75 from GlaxoSmithKline, LLC.
$249.23 from Genentech USA, Inc.
$220.01 from E.R. Squibb & Sons, L.L.C.
$200.00 from COMSORT, Inc
$189.02 from Celgene Corporation
$116.48 from Fidia Pharma USA Inc
$114.11 from Mallinckrodt LLC
$111.48 from Novo Nordisk Inc
$102.99 from Takeda Pharmaceuticals America, Inc.
$96.96 from LILLY USA, LLC
$88.01 from Antares Pharma, Inc.
$66.22 from GENZYME CORPORATION
$58.02 from Iroko Pharmaceuticals, LLC
Payments received by Dr. Francis Lichon, MD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!